Quick Answer
Palomino Laboratories Inc. reported Stockholders Equity of $8.10 million for fiscal year 2025.
Palomino Laboratories Inc. Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $8.10M | +44335.2% |
| 2024 | -$18.3K | +0.0% |
| 2024 | -$18.3K | -768.4% |
| 2023 | -$2.1K | +92.4% |
| 2022 | -$27.8K | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $7.31M | +87763.3% | +1735.3% |
| June 30, 2025 | -$447.2K | -22161.6% | +54.9% |
| March 31, 2025 | -$991.7K | -42008.4% | -5317.1% |
| December 31, 2024 | -$18.3K | -768.4% | -119.4% |
| September 30, 2024 | -$8.3K | +89.4% | -315.3% |
| June 30, 2024 | -$2.0K | +94.4% | +14.7% |
| March 31, 2024 | -$2.4K | +92.5% | -11.7% |
| December 31, 2023 | -$2.1K | +92.3% | +97.3% |
- Palomino Laboratories Inc. showed an increase of +44335.2% in Stockholders Equity compared to the prior fiscal year.
- Over the 2022–2025 period, Palomino Laboratories Inc.’s stockholders equity has grown by 29224.2% (from -$27.8 thousand to $8.10 million).
- The most recent figure is from Palomino Laboratories Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: